The Impact of Exacerbation History on the Safety and Efficacy of Aclidinium in Patients with Chronic Obstructive Pulmonary Disease and Increased Cardiovascular Risk: ASCENT-COPD Trial

PURPOSE: Chronic obstructive pulmonary disease (COPD) exacerbations are associated with increased risk of major adverse cardiovascular events (MACE) and mortality. Here, we investigate whether the safety and efficacy of aclidinium bromide differ due to exacerbation history in patients with COPD and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wise, Robert A, Chapman, Kenneth R, Scirica, Benjamin M, Daoud, Sami Z, Lythgoe, Dan, Garcia-Gil, Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987267/
https://www.ncbi.nlm.nih.gov/pubmed/33776428
http://dx.doi.org/10.2147/COPD.S285068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987267/
https://www.ncbi.nlm.nih.gov/pubmed/33776428
http://dx.doi.org/10.2147/COPD.S285068

Ejemplares similares